Compumed Inc (CMPD) 0.1470 $CMPD
Diagnostic Electrocardiograph (ECG) Market 2014-2020 - Product, End-User & by Lead Type Analysis
M2 - Mon Sep 22, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6mqrkd/diagnostic) has announced the addition of the "Diagnostic Electrocardiograph (ECG) Market by Product, End-user & by Lead Type - Global Forecast to 2020" report to their offering. The overall market was valued at $3,683 million in 2013 and is poised to grow at a CAGR of 5.7% by 2020 The global diagnostic ECG market in the resting system segment had the largest share of the total diagnostic ECG market in 2013 and will continue to grow in the next five years to retain the leading position by 2020. The high growth in holter monitor segment is attributed to the low costs and space efficiency. Factors such as technological advancements in communication, low power circuit design for better and safer ECG devices, portable features with lower power consumption, more accuracy and capacity to incorporate the latest diagnostic features are driving the diagnostic ECG market. North America accounted for the largest market share in the diagnostic ECG market, whereas the APAC region is expected to register the highest growth rate due to its enormous growth opportunities and manufacturing cost benefits. The large patient base and increasing income levels are also expected to propel the growth of this market. The diagnostic ECG devices are increasingly being networked across various hospitals. Most of the larger hospitals are preferring computerization for maintaining electrocardiogram records and investing steadily in data management systems to allow physicians to access the comparative analysis of the patients' overall data. The advanced technologies such as the wireless technologies also provide growth opportunities. Moreover, the rising incidences of cardiac diseases and diseases such as diabetes and hypertension have also contributed to the growth of the diagnostic ECG market. The resting ECG devices segment had the largest share, while the holter monitor systems market was the fastest growing segment in 2013. Due to the tremendous increase in the number of hospitalizations, ranging from extremely serious to basic monitoring, hospitals are increasing the investment in the resting ECG devices segment. These devices can monitor various physiological parameters of a patient in order to have an overview of the patients' health and status. GE Healthcare was the leader in the diagnostic ECG market in 2013. GE also enjoys a high level of brand loyalty amongst customers due to its large product portfolio, good quality products, and an efficient after-sales service. Philips Healthcare distantly followed GE in the diagnostic ECG market in 2013. The other major players in the market are Mindray Medical (China), Mortara Instrument Inc. (U.S.), Spacelabs Healthcare (U.S), Schiller AG (Switzerland), Cardionet (U.S.), Compumed Inc. (U.S.), Nihon Kohden Corporation (Japan), and Welch Allyn (U.S.). Report Scope Electrocardiograph Market, by Segment - Rest System - Stress System - Holter Monitor System Electrocardiograph Market, by Lead Type - Single Lead - 3-6 Lead - 12 Lead - Others Electrocardiograph Market, by End User - Hospitals (Small, Medium, and Large) - Home /Ambulatory Care - Others (Research Centers, Diagnostic Centers, Rehabilitation Centers, Clinics, Physician Offices, and Surgical Centers) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Global Diagnostic ECG Market, By Product 6 Global Diagnostic ECG Market, By Lead Type 7 Global Diagnostic ECG Market, By End User 8 Global Diagnostic ECG Market, Geographical Analysis 9 Competitive Landscape 10 Company Profiles For more information visit http://www.researchandmarkets.com/research/6mqrkd/diagnostic
Diagnostic Electrocardiograph (ECG) Market to 2020: Product (Resting, Stress, Holter Monitor) & Lead Type (Single, 3-6, 12) Analysis
M2 - Wed Jul 23, 9:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nwbk54/diagnostic) has announced the addition of the "Diagnostic Electrocardiograph (ECG) Market by Product, End-user & by Lead Type - Global Forecast to 2020" report to their offering. The overall market was valued at $3,683 million in 2013 and is poised to grow at a CAGR of 5.7% by 2020. The market is driven by the rise in geriatric population, growing incidences of lifestyle diseases, and technological advancements. However, the decline of reimbursement policies will restrain the growth of this market to an extent. The holter monitor ECG devices will be the most fruitful segment for the companies to invest in the coming years. The resting ECG devices segment was the leading segment owing to the expanding geriatric population and growing incidences of cardiac diseases and other lifestyle diseases such as diabetes and hypertension. The holter diagnostic ECG device on the other hand was the fastest growing segment and is expected to grow at a healthy pace in the coming years, driven by the advancements in technology. While segmenting the market with respect to number of leads the 3-6 lead segment had the largest market share followed by the 12 lead segment. The 3-6 lead segment is also expected to grow at the fastest pace in the forecast period from 2013 to 2020. More number of leads captures more signals, thereby giving a detailed outlook. This makes it easier for providers to better interpret the electrical activity of the heart. Thus, 3-6 lead and 12-lead ECG device segments will grow at higher CAGRs than single-lead ECG devices. With respect to the end users, the global diagnostic ECG market is divided into hospitals, home/ambulatory care research centers, diagnostic centers, rehabilitation centers, clinics, physician offices, and surgical centers. The hospital segment will observe a high growth due to the new technologies launched and the purchasing of an entire new suit of diagnostic ECG devices. Report Scope Electrocardiograph Market, by Segment - Rest System - Stress System - Holter Monitor System Electrocardiograph Market, by Lead Type - Single Lead - 3-6 Lead - 12 Lead - Others Electrocardiograph Market, by End User Hospitals (Small, Medium, and Large) Home /Ambulatory Care Others (Research Centers, Diagnostic Centers, Rehabilitation Centers, Clinics, Physician Offices, and Surgical Centers) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Global Diagnostic ECG Market, By Product 6 Global Diagnostic ECG Market, By Lead Type 7 Global Diagnostic ECG Market, By End User 8 Global Diagnostic ECG Market, Geographical Analysis 9 Competitive Landscape 10 Company Profiles - Cardionet Inc. - Compumed Inc. - Ge Healthcare - Mindray Medical International Limited - Mortara Instrument, Inc. - Nihon Kohden Corporation - Royal Philips Healthcare - Schiller AG - Spacelabs Healthcare Inc. - Welch Allyn For more information visit http://www.researchandmarkets.com/research/nwbk54/diagnostic
Global Bone Densitometers Market Report 2014
M2 - Tue Jul 22, 5:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2qpmg5/global_bone) has announced the addition of the "Global Bone Densitometers Market 2014-2018" report to their offering. Advances in bone densitometer technology coupled with an increase in access of these technologies in emerging markets such as China, Brazil, Japan, and India is serving as an opportunity for investors. New product introductions have been observed across a wide range of bone measurement technologies. The most accurate and widely accepted technique is axial/central DEXA. Lunar iDXA for bone health by GE Healthcare and DXA Technology by Hologic are some of the products launched in this market, which enhanced the growth opportunities in emerging economies. According to the report, the Global Bone Densitometers market is driven by several factors, of which the increase in the aging population is one of the major drivers. As a person ages, the incidence of bone-related disorders such as osteoporosis also increases, resulting in the demand for bone densitometers. Further, the report states that one of the main challenges is the high cost of bone densitometers. Despite the numerous benefits, the high cost of treatment options hinders the acceptability among patients. Also, as a result of this, patients are reluctant to opt for such devices and prefer medications. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The Global Bone Densitometry market can be divided into two segments: - Axial Bone Densitometer - Peripheral Bone Densitometer. Key Vendors - CooperSurgical Inc. - Diagnostic Medical Systems S.A - GE Healthcare Ltd - Hologic Inc. Other Prominent Vendors - BeamMed Ltd - CompuMed Inc. - Lone Oak Medical Technologies LLC - Osteometer MediTech Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Technology - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/2q...lobal_bone
Louisiana Organ Procurement Agency Leveraging CompuMed to Secure More Donor Hearts
PR Newswire Europe - Mon Jul 21, 9:28AM CDT
LOS ANGELES, July 21, 2014 /PRNewswire/ --
Concise Analysis of the International Bone Densitometers Market - Forecasts to 2019
M2 - Mon Feb 10, 5:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/jgll5h/bone) has announced the addition of the "Concise Analysis of the International Bone Densitometers Market - Forecasts to 2019" report to their offering. Bone densitometer devices allow non-invasive, quantitative measurement of bone mass or density. Presently, the demand for bone densitometers is high and is continuously risingas it caters to the needs of the growing elderly population and the high incidence rates of osteoporosis and various associated fractures.Various methods available for measuring bone mineral density and strength use ionizing radiation or ultrasound. The preferred sites of bone density measurement are axial/central skeleton (hip and spine) or peripheral skeleton (forearm, wrist, heel, phalanges). At present a broad range of bone densitometers along with number of technologies are available in the market for bone density measurement. The most accurate and widely accepted technique is axial/central dual energy X-ray absorptiometry (DEXA), while axial/central and peripheral quantitative computed tomography (QCT) are the only current methods which provide an actual volumetric measurement of bone mass.Axial DEXA bone densitometers form the largest segment,in the total market, owing to their improved accuracy and precision and wide acceptance by the end users. Need for trained professionals and high cost as well as huge device size leads to lowering the adoption of axial DEXA systems, particularly in financially lagged countries. Thus growing preference for cost containment measures as well as introduction of portable devices along with increase in awareness for disease diagnosis will together aid in sustaining the growing acceptance of bone densitometers worldwide. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Bone Densitometers Market, by Technology, Market Revenue, 2011 - 2019 5 Global Bone Densitometers Market, by End Users, Market Revenue, 2011 - 2019 6 Global Bone Densitometers Market, By Geography, Market Revenue, 2011-2019 7 Competitive Landscape 8 Recommendations 9 Company Profiles Companies Mentioned: - BeamMed Ltd - CompuMed, Inc - CooperSurgical, Inc - Diagnostic Medical Systems SA - GE Healthcare Ltd - Hologic, Inc - Lone Oak Medical Technologies, LLC - Osteometer MediTech, Inc For more information visit http://www.researchandmarkets.com/research/jgll5h/bone
Oculus Innovative Sciences Appoints Jerry McLaughlin to Its Board of Directors
GlobeNewswire - Wed Mar 20, 7:08AM CDT
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) announced today the appointment of John G. (Jerry) McLaughlin to its board of directors. In this role, he will also serve as a non-chairperson member to the company's audit committee and chair of the nominating and corporate governance committee.
CompuMed Announces Management Change
Marketwire - Mon Jan 14, 12:59PM CST
CompuMed, Inc. (PINKSHEETS: CMPD) (www.compumed.net) -- a leader in telemedicine services for patient diagnosis and management -- announced a change in management. Effective December 31, 2012, Maurizio Vecchione resigned from his position as CEO in order to become Vice President of Global Good at Intellectual Ventures. Global Good is a collaborative effort between Intellectual Ventures and Bill Gates to tackle humanity's problems through new inventions and technologies, with a focus on the developing world. Mr. Vecchione will remain a member of CompuMed's Board of Directors.
Diagnostic Electrocardiograph (ECG) Market 2014-2020 - Product, End-User & by Lead Type Analysis
M2 - Mon Sep 22, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6mqrkd/diagnostic) has announced the addition of the "Diagnostic Electrocardiograph (ECG) Market by Product, End-user & by Lead Type - Global Forecast to 2020" report to their offering. The overall market was valued at $3,683 million in 2013 and is poised to grow at a CAGR of 5.7% by 2020 The global diagnostic ECG market in the resting system segment had the largest share of the total diagnostic ECG market in 2013 and will continue to grow in the next five years to retain the leading position by 2020. The high growth in holter monitor segment is attributed to the low costs and space efficiency. Factors such as technological advancements in communication, low power circuit design for better and safer ECG devices, portable features with lower power consumption, more accuracy and capacity to incorporate the latest diagnostic features are driving the diagnostic ECG market. North America accounted for the largest market share in the diagnostic ECG market, whereas the APAC region is expected to register the highest growth rate due to its enormous growth opportunities and manufacturing cost benefits. The large patient base and increasing income levels are also expected to propel the growth of this market. The diagnostic ECG devices are increasingly being networked across various hospitals. Most of the larger hospitals are preferring computerization for maintaining electrocardiogram records and investing steadily in data management systems to allow physicians to access the comparative analysis of the patients' overall data. The advanced technologies such as the wireless technologies also provide growth opportunities. Moreover, the rising incidences of cardiac diseases and diseases such as diabetes and hypertension have also contributed to the growth of the diagnostic ECG market. The resting ECG devices segment had the largest share, while the holter monitor systems market was the fastest growing segment in 2013. Due to the tremendous increase in the number of hospitalizations, ranging from extremely serious to basic monitoring, hospitals are increasing the investment in the resting ECG devices segment. These devices can monitor various physiological parameters of a patient in order to have an overview of the patients' health and status. GE Healthcare was the leader in the diagnostic ECG market in 2013. GE also enjoys a high level of brand loyalty amongst customers due to its large product portfolio, good quality products, and an efficient after-sales service. Philips Healthcare distantly followed GE in the diagnostic ECG market in 2013. The other major players in the market are Mindray Medical (China), Mortara Instrument Inc. (U.S.), Spacelabs Healthcare (U.S), Schiller AG (Switzerland), Cardionet (U.S.), Compumed Inc. (U.S.), Nihon Kohden Corporation (Japan), and Welch Allyn (U.S.). Report Scope Electrocardiograph Market, by Segment - Rest System - Stress System - Holter Monitor System Electrocardiograph Market, by Lead Type - Single Lead - 3-6 Lead - 12 Lead - Others Electrocardiograph Market, by End User - Hospitals (Small, Medium, and Large) - Home /Ambulatory Care - Others (Research Centers, Diagnostic Centers, Rehabilitation Centers, Clinics, Physician Offices, and Surgical Centers) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Global Diagnostic ECG Market, By Product 6 Global Diagnostic ECG Market, By Lead Type 7 Global Diagnostic ECG Market, By End User 8 Global Diagnostic ECG Market, Geographical Analysis 9 Competitive Landscape 10 Company Profiles For more information visit http://www.researchandmarkets.com/research/6mqrkd/diagnostic
Diagnostic Electrocardiograph (ECG) Market to 2020: Product (Resting, Stress, Holter Monitor) & Lead Type (Single, 3-6, 12) Analysis
M2 - Wed Jul 23, 9:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nwbk54/diagnostic) has announced the addition of the "Diagnostic Electrocardiograph (ECG) Market by Product, End-user & by Lead Type - Global Forecast to 2020" report to their offering. The overall market was valued at $3,683 million in 2013 and is poised to grow at a CAGR of 5.7% by 2020. The market is driven by the rise in geriatric population, growing incidences of lifestyle diseases, and technological advancements. However, the decline of reimbursement policies will restrain the growth of this market to an extent. The holter monitor ECG devices will be the most fruitful segment for the companies to invest in the coming years. The resting ECG devices segment was the leading segment owing to the expanding geriatric population and growing incidences of cardiac diseases and other lifestyle diseases such as diabetes and hypertension. The holter diagnostic ECG device on the other hand was the fastest growing segment and is expected to grow at a healthy pace in the coming years, driven by the advancements in technology. While segmenting the market with respect to number of leads the 3-6 lead segment had the largest market share followed by the 12 lead segment. The 3-6 lead segment is also expected to grow at the fastest pace in the forecast period from 2013 to 2020. More number of leads captures more signals, thereby giving a detailed outlook. This makes it easier for providers to better interpret the electrical activity of the heart. Thus, 3-6 lead and 12-lead ECG device segments will grow at higher CAGRs than single-lead ECG devices. With respect to the end users, the global diagnostic ECG market is divided into hospitals, home/ambulatory care research centers, diagnostic centers, rehabilitation centers, clinics, physician offices, and surgical centers. The hospital segment will observe a high growth due to the new technologies launched and the purchasing of an entire new suit of diagnostic ECG devices. Report Scope Electrocardiograph Market, by Segment - Rest System - Stress System - Holter Monitor System Electrocardiograph Market, by Lead Type - Single Lead - 3-6 Lead - 12 Lead - Others Electrocardiograph Market, by End User Hospitals (Small, Medium, and Large) Home /Ambulatory Care Others (Research Centers, Diagnostic Centers, Rehabilitation Centers, Clinics, Physician Offices, and Surgical Centers) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Global Diagnostic ECG Market, By Product 6 Global Diagnostic ECG Market, By Lead Type 7 Global Diagnostic ECG Market, By End User 8 Global Diagnostic ECG Market, Geographical Analysis 9 Competitive Landscape 10 Company Profiles - Cardionet Inc. - Compumed Inc. - Ge Healthcare - Mindray Medical International Limited - Mortara Instrument, Inc. - Nihon Kohden Corporation - Royal Philips Healthcare - Schiller AG - Spacelabs Healthcare Inc. - Welch Allyn For more information visit http://www.researchandmarkets.com/research/nwbk54/diagnostic
Global Bone Densitometers Market Report 2014
M2 - Tue Jul 22, 5:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2qpmg5/global_bone) has announced the addition of the "Global Bone Densitometers Market 2014-2018" report to their offering. Advances in bone densitometer technology coupled with an increase in access of these technologies in emerging markets such as China, Brazil, Japan, and India is serving as an opportunity for investors. New product introductions have been observed across a wide range of bone measurement technologies. The most accurate and widely accepted technique is axial/central DEXA. Lunar iDXA for bone health by GE Healthcare and DXA Technology by Hologic are some of the products launched in this market, which enhanced the growth opportunities in emerging economies. According to the report, the Global Bone Densitometers market is driven by several factors, of which the increase in the aging population is one of the major drivers. As a person ages, the incidence of bone-related disorders such as osteoporosis also increases, resulting in the demand for bone densitometers. Further, the report states that one of the main challenges is the high cost of bone densitometers. Despite the numerous benefits, the high cost of treatment options hinders the acceptability among patients. Also, as a result of this, patients are reluctant to opt for such devices and prefer medications. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The Global Bone Densitometry market can be divided into two segments: - Axial Bone Densitometer - Peripheral Bone Densitometer. Key Vendors - CooperSurgical Inc. - Diagnostic Medical Systems S.A - GE Healthcare Ltd - Hologic Inc. Other Prominent Vendors - BeamMed Ltd - CompuMed Inc. - Lone Oak Medical Technologies LLC - Osteometer MediTech Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Technology - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/2q...lobal_bone
Louisiana Organ Procurement Agency Leveraging CompuMed to Secure More Donor Hearts
PR Newswire Europe - Mon Jul 21, 9:28AM CDT
LOS ANGELES, July 21, 2014 /PRNewswire/ --
Concise Analysis of the International Bone Densitometers Market - Forecasts to 2019
M2 - Mon Feb 10, 5:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/jgll5h/bone) has announced the addition of the "Concise Analysis of the International Bone Densitometers Market - Forecasts to 2019" report to their offering. Bone densitometer devices allow non-invasive, quantitative measurement of bone mass or density. Presently, the demand for bone densitometers is high and is continuously risingas it caters to the needs of the growing elderly population and the high incidence rates of osteoporosis and various associated fractures.Various methods available for measuring bone mineral density and strength use ionizing radiation or ultrasound. The preferred sites of bone density measurement are axial/central skeleton (hip and spine) or peripheral skeleton (forearm, wrist, heel, phalanges). At present a broad range of bone densitometers along with number of technologies are available in the market for bone density measurement. The most accurate and widely accepted technique is axial/central dual energy X-ray absorptiometry (DEXA), while axial/central and peripheral quantitative computed tomography (QCT) are the only current methods which provide an actual volumetric measurement of bone mass.Axial DEXA bone densitometers form the largest segment,in the total market, owing to their improved accuracy and precision and wide acceptance by the end users. Need for trained professionals and high cost as well as huge device size leads to lowering the adoption of axial DEXA systems, particularly in financially lagged countries. Thus growing preference for cost containment measures as well as introduction of portable devices along with increase in awareness for disease diagnosis will together aid in sustaining the growing acceptance of bone densitometers worldwide. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Bone Densitometers Market, by Technology, Market Revenue, 2011 - 2019 5 Global Bone Densitometers Market, by End Users, Market Revenue, 2011 - 2019 6 Global Bone Densitometers Market, By Geography, Market Revenue, 2011-2019 7 Competitive Landscape 8 Recommendations 9 Company Profiles Companies Mentioned: - BeamMed Ltd - CompuMed, Inc - CooperSurgical, Inc - Diagnostic Medical Systems SA - GE Healthcare Ltd - Hologic, Inc - Lone Oak Medical Technologies, LLC - Osteometer MediTech, Inc For more information visit http://www.researchandmarkets.com/research/jgll5h/bone
Oculus Innovative Sciences Appoints Jerry McLaughlin to Its Board of Directors
GlobeNewswire - Wed Mar 20, 7:08AM CDT
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) announced today the appointment of John G. (Jerry) McLaughlin to its board of directors. In this role, he will also serve as a non-chairperson member to the company's audit committee and chair of the nominating and corporate governance committee.
CompuMed Announces Management Change
Marketwire - Mon Jan 14, 12:59PM CST
CompuMed, Inc. (PINKSHEETS: CMPD) (www.compumed.net) -- a leader in telemedicine services for patient diagnosis and management -- announced a change in management. Effective December 31, 2012, Maurizio Vecchione resigned from his position as CEO in order to become Vice President of Global Good at Intellectual Ventures. Global Good is a collaborative effort between Intellectual Ventures and Bill Gates to tackle humanity's problems through new inventions and technologies, with a focus on the developing world. Mr. Vecchione will remain a member of CompuMed's Board of Directors.
